Moreover, RGL2 knockdown was suppressed, but overexpression promoted the metastatic potential of CRC cells in vitro and in vivo by fostering the progression of epithelial-mesenchymal transition and the activity of β-catenin. The gene discussed is RGL2; the disease is colorectal carcinoma.